ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 822

Greater Than Expected Increased Mortality Following Fragility Fractures in Women and Men with Rheumatoid Arthritis

Shreyasee Amin1, Sherine E. Gabriel2, Sara J. Achenbach3, Elizabeth J. Atkinson3 and L. Joseph Melton III4, 1Rheumatology and Health Sciences Research, Mayo Clinic, Rochester, MN, 2Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Department of Hlth Sciences, Mayo Clinic, Rochester, MN

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: fractures, morbidity and mortality and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Women and men with RA are at an increased risk for fracture [fx] as well as greater overall mortality. It is recognized that in the general population, overall mortality among those with a fx is increased. We sought to determine whether an incident fx following the diagnosis of RA contributes to an excess mortality beyond what would be expected for an incident fracture in those without RA.

Methods: We studied a population-based inception cohort (age ≥18 yrs), who fulfilled 1987 American College of Rheumatology criteria for RA between 1955-2007, and an equal number of age- and sex-matched non-RA subjects from the same underlying population, who were followed until death or last available follow-up. All incident fxs were identified through a complete review (inpatient and outpatient) of medical records. We excluded from analyses pathologic fxs and fxs resulting from severe trauma (e.g. motor vehicle accidents, etc.). Cox proportional models were used to examine the risk for death following the first incident non-pathologic fracture resulting from no more than moderate trauma [moderate trauma fx] after RA diagnosis, or equivalent index date in non-RA subjects. All analyses were adjusted for age and sex, and fractures were modeled as a time-dependent covariate. In RA subjects, we also examined in separate analyses whether steroid use, being seropositive, or having nodules or erosions (modeled as time-dependent covariates) could account for the risk of death following fracture.

Results: In 1171 RA subjects, (822 women and 349 men, mean age at RA diagnosis ± SD: 56 ± 16 yrs and 58 ± 14 yrs, respectively), followed for 15,707 person-yrs [p-y], 440 had any moderate trauma fx, while 535 died over the available follow-up. In sex- and age-matched non-RA subjects, 374 had any moderate trauma fx and 441 died over 17,643 p-y follow-up. In RA subjects, a moderate trauma fx increased the risk for death (Hazard Ratio [HR], 2.2; 95% CI: 1.8, 2.6). An increased risk for death was also observed in non-RA subjects following a moderate trauma fx (HR: 1.5, 95% CI: 1.2, 1.9) although this risk was significantly lower (p = 0.04) than in RA. In RA subjects, any moderate trauma fracture remained a significant predictor of death even after adjusting for steroid use, being seropositive, or having nodules or erosions (HR: 1.9, 95% CI: 1.6, 2.3).

Conclusion: A moderate trauma fracture in RA is associated with a greater than expected excess mortality.  Identifying characteristics or other co-morbidities among those with RA who fracture may help explain this excess risk of death following fractures.


Disclosure:

S. Amin,

Merck Pharmaceuticals,

5;

S. E. Gabriel,

Pfizer Inc,

2,

Roche Pharmaceuticals,

5;

S. J. Achenbach,
None;

E. J. Atkinson,
None;

L. J. Melton III,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/greater-than-expected-increased-mortality-following-fragility-fractures-in-women-and-men-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology